Sign inGet started

Levitsky Hyam

Insider CIK 1375792 · JUNO See Remarks · REPL Director · IPSC President of R&D

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
REPL Replimune Group, Inc. A Award deriv2024-04-012024-04-0332,000— $032,000SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2024-03-072024-03-11146,000— $0146,000SEC↗
IPSC Century Therapeutics, Inc. A Award2024-03-072024-03-1124,000— $024,000SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2023-04-122023-04-14131,250— $0131,250SEC↗
REPL Replimune Group, Inc. A Award deriv2023-04-012023-04-0425,200— $025,200SEC↗
REPL Replimune Group, Inc. A Award deriv2022-04-012022-04-0516,500— $016,500SEC↗
IPSC Century Therapeutics, Inc. A Award deriv2022-01-252022-01-27105,000— $0105,000SEC↗
REPL Replimune Group, Inc. A Award deriv2021-04-012021-04-0516,500— $016,500SEC↗
REPL Replimune Group, Inc. A Award deriv2020-04-012020-04-0216,500— $016,500SEC↗
REPL Replimune Group, Inc. A Award deriv2019-04-012019-04-0313,500— $013,500SEC↗
REPL Replimune Group, Inc. A Award deriv2018-07-242018-07-2627,000— $027,000SEC↗
JUNO Juno Therapeutics, Inc. A Award deriv2017-02-072017-02-0968,182— $068,182SEC↗
JUNO Juno Therapeutics, Inc. A Award2017-02-072017-02-0914,634— $0131,334SEC↗
JUNO Juno Therapeutics, Inc. S Sale2016-06-172016-06-21300$43.20 $13.0K116,700SEC↗
JUNO Juno Therapeutics, Inc. S Sale2016-06-172016-06-2112,118$42.76 $518.2K117,000SEC↗
JUNO Juno Therapeutics, Inc. F Tax w/h2016-05-272016-05-2716,454$42.04 $691.7K129,118SEC↗
JUNO Juno Therapeutics, Inc. A Award deriv2016-02-022016-02-04100,000— $0100,000SEC↗
JUNO Juno Therapeutics, Inc. A Award deriv2015-05-282015-06-01175,000— $0175,000SEC↗
JUNO Juno Therapeutics, Inc. A Award2015-05-282015-06-01145,000— $0145,000SEC↗